Abstract
A comparative study between two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in the co-existence of the probable carcinogenic oxidative degradation product of timolol maleate in their ophthalmic formulation was demonstrated. The first method established the thin-layer chromatography coupled with the densitometric determination of the analyzed spots, using silica gel TLC aluminum plates F254 and a developing system of chloroform: methanol: ammonia (6:1:0.1, in volumes) at room temperature to give good separation for the three investigated components, where retardation factors for the oxidative degradation product of timolol maleate, brinzolamide and timolol maleate were (Rf 0.21), (Rf 0.46), and (Rf 0.55), respectively. The linear ranges were 2–10 and 3–16 μg/band for brinzolamide and timolol maleate, respectively. In the second method, high performance liquid chromatography (HPLC), photo diode array detection was used on a Eurospher 5 µm C18 100 Å (4.6 × 250 mm) column, using triethylamine pH 3.5, adjusted by glacial acetic acid: acetonitrile (20:80, v/v) at a rate of 0.5 mL per minute. An acceptable separation was achieved, where the retention times for timolol maleate, the oxidative degradation product of timolol maleate and brinzolamide, were (Rt 3.6), (Rt 4.7), and (Rt 5.6), respectively. Linearity covered a range of 20–120 μg/mL for both drugs. It has been proved previously that timolol maleate is liable to oxidation, giving a high-probability carcinogenic product in female mice. The validation for the new proposed stability-indicating methods was optimized in line with the ICH guidelines with good outcomes. It is worth noting that the HPLC-DAD method showed superior separation, economic and time-saving results, while TLC method was more sensitive.
Subject
Filtration and Separation,Analytical Chemistry
Reference36 articles.
1. The united states pharmacopoeia and national formulary in their relation to the food and drug laws;Todd;J. Am. Pharm. Assoc.,1913
2. Maryadele, J., Heckelman, P.E., Koch, C.B., and Roman, K.J. (2006). The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, Merck & Co.
3. Catteral, W.A., and Goodman, M.K. (2006). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, Mc Graw Hill. [11th ed.]. Chapter 14.
4. Sharma, H.L., and Sharma, K.K. (2007). Principles of Pharmacology, Paras Medical Publisher. [2nd ed.].
5. Analytical method development and validation for the determination of brinzolamide by RP-HPLC;Balakrishna;JDDT,2020